Current developments in using meso-(Tetra)substituted porphyrins for PDT
Item Type:Book Chapter
Citation:Current developments in using meso-(Tetra)substituted porphyrins for PDT, Pandey, R. K.; Kessel, D.; Dougherty, T. J. , Handbook of Photodynamic Therapy: Updates on Recent Applications of Porphyrin-Based Compounds, Singapore, World Scientific,, 2016, 95 149, Shaker, Y. M.; Sweed, A. M. K.; Moylan, C.; Rogers, L.; Ryan, A. A.; Petitdemange, R.; Senge, M. O.
MS296_Tara.pdf (Published (author's copy) - Peer Reviewed) 775.1Kb
The goal of this chapter is to describe recent advances in the development and use of meso-tetrasubstituted porphyrins in photodynamic therapy (PDT). The focus is on analogues of 5,10,15,20- tetrakis(3-hydroxyphenyl)chlorin (m-THPC) and related second and third generation photosensitizers (PSs) currently under development. There has been a rapid growth in the literature on this topic. The chapter summarizes the conjugation of meso-tetrasubstituted porphyrin photosensitizers with biologically active elements (amino acids, bile acids, peptides, folic acid, sugars, oligonucleotides, monoclonal antibody), where most of the contemporary work also focuses. Porphyrin isomers and core modified porphyrins will also be discussed, followed by a brief discussion of nanoparticle derived systems.
Author: SENGE, MATHIAS
Other Titles:Handbook of Photodynamic Therapy: Updates on Recent Applications of Porphyrin-Based Compounds
Type of material:Book Chapter
Availability:Full text available